ESC 365 - Q&A and discussion

Open Access

Q&A and discussion

Session: Personalised anticoagulation therapy in eligible patients with atrial fibrillation

Topic: Oral Anticoagulation

Speaker: Doctor J. Weitz (Hamilton, CA) Professor H. Heidbuchel (Antwerp, BE) Doctor M. Akao (Kyoto, JP)

Sponsored by Daiichi Sankyo

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speakers

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

31 presentations

1 follower

Professor Hein Heidbuchel

University Hospital Antwerp, Antwerp (Belgium)

59 presentations

5 followers

Doctor Masaharu Akao

Kyoto Medical Centre, Kyoto (Japan)

7 presentations

0 follower

4 more presentations in this session

Welcome and introduction

Speaker: Doctor J. Weitz (Hamilton, CA)

Choose the right anticoagulant for the eligible patient in the right dose

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Challenging clinical scenarios for therapeutic anticoagulation: a practical approach

Speaker: Doctor M. Akao (Kyoto, JP)

Conclusions and close

Speaker: Doctor J. Weitz (Hamilton, CA)

Access the full session

Personalised anticoagulation therapy in eligible patients with atrial fibrillation

Speakers: Doctor J. Weitz, Professor H. Heidbuchel, Doctor M. Akao, Doctor J. Weitz, Professor H. Heidbuchel...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources